A Democratic U.S. senator has called out pharmaceutical companies for opposing legal marijuana. Gillibrand made the statement on “Good Day New York” in response to a question about the gateway drug effect of marijuana. Her remarks were a clear message that marijuana should be legalized. She noted that pharma giants are closely watching the legalization of marijuana. But she also noted that the debate about legalization of marijuana has the potential to benefit the public.
To support legal marijuana, the Democratic senator’s bill includes provisions that would expunge nonviolent marijuana convictions, allow for federal and state sentencing reviews, and make Small Business Administration loans available to cannabis businesses. The bill is estimated to save the federal government hundreds of millions of dollars over the next decade. It also aims to end the harm done to communities of color by the War on Drugs. The senator also said it would support the entry of low-income and minority individuals into the legal marijuana industry.
Pro-cannabis lawmakers and advocates worry about Republican leadership in the Senate. The party may not control both houses in January, which would make it difficult for marijuana businesses to access financial services. However, it is a strong possibility that the Democratic Party will take the lead and pass a bill to legalize marijuana in the United States. The question is, will it be enough? The answer, of course, depends on the voters.
The bill would also protect financial institutions that do business with state-licensed marijuana businesses. Banks that don’t participate in legal marijuana businesses risk being prosecuted by federal authorities. The bill has the backing of the American Bankers Association. It has already passed the House five times in various forms, and Schumer is currently soliciting input from senators across the aisle. It would be better if the bill passed with bipartisan support than passing it with just one party.
Pro-pot groups and drug industry lobbyists are shady. Their efforts are motivated by money. These groups get federal grants to promote law enforcement. They then compensate researchers who oppose legal marijuana. Insys is an example of this. Its goal is to protect their market share. Pharmaceutical companies want to keep their customers on painkillers, even though cannabis is cheaper. Furthermore, it is the prison-industrial complex that wants more prisons to keep more criminals in jail.
While the medical marijuana debate continues to dominate headlines, there’s no evidence that legalization will bring health benefits to the public. However, it will hurt big corporations, as commercial marijuana will be a lucrative business that targets children and teenagers. Senator Calls Out Big Pharma For Opposing Legal Marijuana
Pro-legalization campaigns are underway in many states. This is especially true in the presidential election year, when marijuana policy may come to the forefront of issues in the general election. But in the meantime, we should be patient. Marijuana legalization campaigns marijuana seeds usa are a good start. There are a few other issues we need to work on to make this a reality. For the record, there are two major political players in the race for marijuana legalization: President Trump and Governor Christie. The president can’t afford to ignore it.
As the opioid crisis rages across the nation, marijuana is an important issue for the state of New Jersey. The drug industry is destroying communities, while reducing painkillers will benefit the public in general. Moreover, less painkillers would mean less money for pharma companies. Thankfully, medical research has shown that cannabis is an effective solution to chronic pain. But the issue remains: how much money will the government spend?
House Bill 1 (which established a referendum to legalize medical marijuana nationwide) passed the Senate Finance Committee on Thursday, despite a small minority of Republicans. The measure passed the committee by a vote lastest about marijuana of seven to four. Although it is highly unlikely to be approved by the Senate, the bill’s passage is a welcome development. If passed, it will make it possible to begin legal marijuana businesses across the country.
While the legalization of recreational marijuana is welcomed by most Americans, some worry about the impact on the health system. The pharmaceutical industry is heavily involved in marijuana enforcement, which harms teens and adults alike. Legalization of marijuana will increase drug use among teens and increase traffic accidents and deaths. Legalization will also lead to more medical marijuana-related emergency room visits. And, the addiction to the drug will increase the number of mental health problems among young people.